Medicover AB (publ)
MCOV-B
Rang in Aktien
#3955
Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ)... Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ) is a prominent international provider of both healthcare and diagnostic services. The company operates across numerous countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It is structured into two main divisions: Healthcare Services and Diagnostic Services. Through its diagnostic division, Medicover performs a comprehensive array of specialized tests, which include analyses for allergy and autoimmune conditions; bacteriology and parasitology; biochemistry and immunochemistry; blood group diagnostics and transfusion medicine; tumour markers; clinical chemistry; cellular analyses like cytology, haematology, and histopathology; human genetics; hygiene; general immunology; infectious diseases; microbiology; molecular biology; and pharmacology/toxicology. Medicover maintains a substantial operational footprint, encompassing 97 clinical laboratories, 733 blood-drawing points, and 26 clinics dedicated to diagnostic services across 10 countries. Its healthcare segment further comprises 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. The company caters to a broad customer base, serving corporate entities, private individuals, direct patients, and public sector payers.
Aktienkurs
$27.03
Marktkapitalisierung
$4.11B
Veränderung (1 Tag)
0.56%
Veränderung (1 Jahr)
-1.61%
Land
SE
Handel Medicover AB (publ) (MCOV-B)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Medicover AB (publ) (MCOV-B)
Anzahl der ausstehenden Aktien zum October 2026: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Medicover AB (publ) beträgt die aktuelle Anzahl der ausstehenden Aktien 0. Am Ende von October 2026 hatte das Unternehmen 0 ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Medicover AB (publ) (MCOV-B) von 2014 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2025 | 150.70M | 0.38% |
| 2024 | 150.14M | 0.52% |
| 2023 | 149.36M | 0.43% |
| 2022 | 148.72M | 0.25% |
| 2021 | 148.35M | 4.66% |
| 2020 | 141.75M | 6.31% |
| 2019 | 133.34M | 0.00% |
| 2018 | 133.34M | 11.87% |
| 2017 | 119.19M | 25.44% |
| 2016 | 95.01M | -28.74% |
| 2015 | 133.34M | 0.00% |
| 2014 | 133.34M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 222.83M | - |
US
|
|
| - | - |
DE
|
|
| 83.52M | - |
US
|
|
| 350.00M | - |
SA
|
|
| 2.18B | - |
BR
|
